Ask Dr. Durie | International Myeloma Foundation

Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma?

February 2

Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma?

Is there a new highly sensitive blood test to detect minimal residual disease?

January 26

Is there a new highly sensitive blood test to detect minimal residual disease?

Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)?

January 19

Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)?

Do patients with MGUS need to have a bone marrow test?

January 12

Do patients with MGUS need to have a bone marrow test?

Is the IMF’s ASCENT trial curing smoldering myeloma patients?

December 15

Is the IMF’s ASCENT trial curing smoldering myeloma patients?

Ask Dr. Durie: What treatment options are available to manage myeloma-related bone disease?

December 8

What treatment options are available to manage myeloma-related bone disease?

Ask Dr. Durie: What is FISH testing?

October 20

What is FISH testing?

Are there treatment options available to relapsed myeloma patients?

October 13

Are there treatment options available to relapsed myeloma patients?

What is minimal residual disease?

October 6

What does it mean when a myeloma patient is MRD negative?

Frontline treatment options for new myeloma patients

September 29

What treatment is recommended for a newly diagnosed patient?

Should patients see a doctor who specializes in multiple myeloma?

September 22

Should patients see a multiple myeloma expert?

Can multiple myeloma be monitored with only blood testing?

September 15

Can myeloma be monitored using only blood testing?

Subscribe to Ask Dr. Durie

Give Where Most Needed